amantadine and isoproterenol

amantadine has been researched along with isoproterenol in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19904 (30.77)18.7374
1990's1 (7.69)18.2507
2000's3 (23.08)29.6817
2010's5 (38.46)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Lombardo, F; Obach, RS; Waters, NJ1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Bellman, K; Knegtel, RM; Settimo, L1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Jones, LH; Nadanaciva, S; Rana, P; Will, Y1
Doyle, D; Parkes, JD; Vollum, DI1
Kovács, T; Mészáros, J; Szegi, J1
Busse, E; Helmholz, M; Magdon, E1
Pratt, CM; Sartori, M; Young, JB1
Northover, BJ1

Reviews

1 review(s) available for amantadine and isoproterenol

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

12 other study(ies) available for amantadine and isoproterenol

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
    Pharmaceutical research, 2014, Volume: 31, Issue:4

    Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation

2014
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
    Bioorganic & medicinal chemistry letters, 2016, 08-15, Volume: 26, Issue:16

    Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone

2016
Livedo reticularis during amantadine treatment.
    British medical journal, 1971, Jun-12, Volume: 2, Issue:5762

    Topics: Aged; Amantadine; Ankle; Blood Vessels; Edema; Epinephrine; Female; Humans; Isoproterenol; Male; Middle Aged; Norepinephrine; Parkinson Disease; Posture; Skin; Skin Diseases

1971
Comparative studies on the positive inotropic effect of isoproterenol and bromobenzoyl-methyladamantylamine in guinea pig ventricular myocardium.
    Acta physiologica Hungarica, 1984, Volume: 64, Issue:1

    Topics: Action Potentials; Amantadine; Animals; Calcium; Cardiotonic Agents; Female; Guinea Pigs; Heart Ventricles; Ion Channels; Isoproterenol; Male; Myocardial Contraction; Myocardium; Potassium; Sodium; Stimulation, Chemical

1984
[Age-related changes of cAMP and prostaglandin content in the brain and lymphocytes of spontaneously tumor-producing C3H mice].
    Onkologie, 1981, Volume: 4, Issue:6

    Topics: Adenylyl Cyclases; Age Factors; Amantadine; Animals; Brain Chemistry; Cyclic AMP; Diencephalon; Dopamine; Female; Isoproterenol; Lymphocytes; Male; Mice; Mice, Inbred C3H; Prostaglandins; Prostaglandins E; Prostaglandins F

1981
Torsade de Pointe. Malignant cardiac arrhythmia induced by amantadine poisoning.
    The American journal of medicine, 1984, Volume: 77, Issue:2

    Topics: Adult; Amantadine; Dopamine; Electrocardiography; Female; Heart Arrest; Humans; Isoproterenol; Suicide, Attempted; Tachycardia; Ventricular Fibrillation

1984
Effect of pre-treating rat atria with potassium channel blocking drugs on the electrical and mechanical responses to phenylephrine.
    Biochemical pharmacology, 1994, Jun-15, Volume: 47, Issue:12

    Topics: 4-Aminopyridine; Action Potentials; Adenosine; Amantadine; Amifampridine; Animals; Cesium; Chlorides; Heart Atria; In Vitro Techniques; Isoproterenol; Phenylephrine; Potassium Channel Blockers; Rats; Sparteine; Systole

1994